Cysteinyl leukotriene receptor antagonist regulates allergic airway inflammation in an organ- and cytokine-specific manner

Medical Science Monitor

Volumn 20, Issue , 2014, Pages 297-302

  Kawano, Tetsuya ^a   Matsuse, Hiroto ^a   Tsuchida, Tomoko ^a   Fukahori, Susumu ^a   Fukushima, Chizu ^a   Nishino, Tomoya ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Asthma; Leukotriene antagonists; Lymphoid tissue; Pranlukast

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PRANLUKAST; CHROMONE DERIVATIVE; CYTOKINE; LEUKOTRIENE D4 RECEPTOR; LEUKOTRIENE RECEPTOR;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATOPHAGOIDES FARINAE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; IMMUNIZATION; LUNG LAVAGE; MEDIASTINUM LYMPH NODE; MICROPHOTOGRAPHY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; TH1 TH2 BALANCE; ANALYSIS OF VARIANCE; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; CELL COUNT; CYTOLOGY; DRUG EFFECTS; LUNG; LYMPH NODE; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; SPLEEN;

ADRENAL CORTEX HORMONES; ANALYSIS OF VARIANCE; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CHROMONES; CYTOKINES; FEMALE; LEUKOCYTES, MONONUCLEAR; LEUKOTRIENE ANTAGONISTS; LUNG; LYMPH NODES; MICE; MICE, INBRED BALB C; RECEPTORS, LEUKOTRIENE; SPLEEN;

EID: 84895141726     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.889865     Document Type: Article

References (25)

1. Busse WW, Lemanske RF: Asthma (Review). N Engl J Med, 2001; 344: 350-62
2. Boyce JA, Bochner B, Finkelman FD, Rothenberg ME: Advances in mechanisms of asthma, allergy, and immunology in 2011. J Allergy Clin Immunol, 2011; 129(2): 335-41
3. O'Byrne PM: Therapeutic strategies to reduce asthma exacerbations. J Allergy Clin Immunol, 2011; 128(2): 257-63
4. Tantisira KG, Drazen JM: Genetics and pharmacogenetics of the leukotriene pathway. J Allergy Clin Immunol, 2009; 124(3): 422-27
5. Trzcinska H, Przybylski G, Kozlowski B, Derdowski S: Analysis of the relation between level of asthma control and depression and anxiety. Med Sci Monit, 2012; 18(3): CR190-94
6. Yalcin AD, Basaran S, Bisgin A et al: Pollen aero allergens and the climate in Mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients. Med Sci Monit, 2014; 20: 102-10
7. Erceg D, Nanadic N, Placec D et al: Inhaled corticosteroids used for the control of asthma in a "real-life" setting do not affect linear growth velocity in prepubertal children. Med Sci Monit, 2012; 18(9): CR564-68
8. Ogawa Y, Calhoun WJ: The role of leukotrienes in airway inflammation. J Allergy Clin Immunol, 2006; 118(4): 788-98
9. Obase Y, Shimoda T, Matsuse H et al: The position of pranlukast, a cysteinyl leukotriene receptor antagonist, in the long-term treatment of asthma. 5-year follow-up study. Respiration, 2004; 71(3): 225-32
10. Tomari S, Shimoda T, Kawano T et al: Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma. Ann Allergy Asthma Immunol, 2001; 87: 156-61
11. Obase Y, Shimoda T, Tomari S et al: Efficacy and safety of long-term treatment of asthmatic patients with pranlukast, a cysteinyl-leukotriene-receptor antagonist: four-year follow-up study. Ann Allergy Asthma Immunol, 2001; 87: 43-47
12. Holgate ST: Pathophysiology of asthma: what has our current understanding taught us about new therapeutic approaches? J Allergy Clin Immunol, 2011; 128(3): 495-505
13. Montuschi P, Peters-Golden ML: Leukotriene modifiers for asthma treatment. Clin Exp Allergy, 2010; 40(12): 1732-41
14. Lan F, Liu K, Zhang J et al: Th17 response is augmented in OVA-induced asthmatic mice exposed to HDM. Med Sci Monit, 2011; 17(5): BR132-38
15. Nguyen TH, Casale TB: Immune modulation for treatment of allergic disease. Immuno Rev, 2011; 242(1): 258-71
16. Robinson DS: The role of the T cell in asthma J Allergy Clin Immunol, 2010; 126(6): 1081-91
17. Kawano T, Matsuse H, Kondo Y et al: Cysteinyl leukotrienes induce nuclea factor kappa b activation and RANTES production in a murine model of asthma. J Allergy Clin Immunol, 2003; 112(2): 369-74
18. Matsuse H, Behera AK, Kumar M et al: Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness. J Immunol, 2000; 164: 6583-92
19. Matsuse H, Hirose H, Fukahori S et al: Regulation of dendritic cell functions against harmful respiratory pathogens by a cysteinyl leukotrienes receptor antagonists. Allergy Rhinol, 2012; 3(1): e30-34
20. Uunderwood DC, Osborn RR, Newsholme SJ et al: Persistent airway eosinophilia after leukotriene (LT). D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody. Am J Respir Crit Care Med, 1996; 154: 850-57
21. Ihaku D, Cameron L, Suzuki M et al: Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to antigen, airway eosinophilia, and IL-5-expressing cells in Brown Norway rats. J Allergy Clin Immunol, 1999; 104: 1147-54
22. Tohda Y, Nakahara H, Kubo H et al: Effects of ONO-1078 (pranlukast). on cytokine production in peripheral blood mononuclear cells of patients with bronchial asthma. Clin Exp Allergy, 1999; 29: 1532-36
23. Singh RK, Gupta S, Dastidar S, Ray A: Cysteinyl leukotrienes and their receptors: Molecular and functional characteristics. Pharmacol, 2010; 85: 336-49
24. Schleimer RP, Schulman ES, MacGlashan DW Jr et al: Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J clin Invest, 1983; 71(6): 1830-35
25. O'Shaughnessy KM, Wellings R, Gillies B, Fuller RW: Differential effects of fluticasone propionate on allergen-evoked bronchocomstriction and increased erinary leukotriene E4 excretion. Am Rev Respir Dis, 1993; 147(6 Pt 1): 1472-76